RAB1A and metastatic malignant neoplasm in the lymph nodes: Among all 406 ypT0–2 patients, 66 (16.3%) had lymph node metastasis: 20.8% among ypT2, 17.1% among ypT1, and 9.1 % among ypT0 patients.